EP2707385
Fyrir-samruna-RSV-F-mótefnavakar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.5.2012EP published:
20.9.2017EP application number:
12722057.2
EP translation filed:
1.11.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
13.5.2032Expiry date:
13.5.2026Next due date:
31.5.2026
Title:
PRE-FUSION RSV F ANTIGENS
Timeline
Today
14.5.2012EP application
20.9.2017EP Publication
1.11.2017Translation submitted
15.11.2017Registration published
13.5.2026Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut 89, 1330, Rixensart, BE
Inventor
Name:
SWANSON, KurtAddress:
Emeryville, CA, US
Name:
CARFI, AndreaAddress:
Emeryville, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161486005 PDate:
13.5.2011Country:
US
Classification
Categories:
C07K 14/135
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 12.4.2018
Expires: 13.5.2019
Payer: Örn Þór, slf.
Number: 8
Paid: 11.4.2019
Expires: 13.5.2020
Payer: Örn Þór, slf.
Number: 9
Paid: 14.4.2020
Expires: 13.5.2021
Payer: Örn Þór slf.
Number: 10
Paid: 21.4.2021
Expires: 13.5.2022
Payer: Patice ehf.
Number: 11
Paid: 19.4.2022
Expires: 13.5.2023
Payer: Patice ehf.
Number: 12
Paid: 22.4.2023
Expires: 13.5.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 19.4.2024
Expires: 13.5.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.5.2025
Expires: 13.5.2026
Payer: Árnason Faktor ehf.